雪榕生物：上半年归母净利润亏损1.03亿元

Group 1 - The core viewpoint of the article is that Xuerong Bio reported a significant decline in revenue and incurred a net loss in the first half of 2025 [1] Group 2 - The company achieved an operating income of 791 million yuan, which represents a year-on-year decrease of 26.17% [1] - The net profit attributable to the parent company was a loss of 103 million yuan [1]